These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28951665)

  • 1. Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction.
    Siriangkhawut M; Tansakul P; Uchaipichat V
    Saudi Pharm J; 2017 Sep; 25(6):823-829. PubMed ID: 28951665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries.
    Chaipichit N; Krska J; Pratipanawatr T; Jarernsiripornkul N
    Int J Clin Pharm; 2015 Apr; 37(2):355-64. PubMed ID: 25630895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicians' Experiences as Patients with Statin Side Effects: A Case Series.
    Koslik HJ; Meskimen AH; Golomb BA
    Drug Saf Case Rep; 2017 Dec; 4(1):3. PubMed ID: 28217821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand.
    Rattanachotphanit T; Limwattananon C; Waleekhachonloet O
    Ther Adv Drug Saf; 2019; 10():2042098618820502. PubMed ID: 30728944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin-induced myopathy, the role of interaction with diltiazem and genetic predisposition.
    Hu M; Mak VW; Tomlinson B
    J Clin Pharm Ther; 2011 Jun; 36(3):419-25. PubMed ID: 21545622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk for significant creatine kinase elevation with statins.
    Stolcpart RS; Olson KL; Delate T; Rasmussen J; Rehring TF; Merenich JA
    Am J Cardiovasc Drugs; 2010; 10(3):187-92. PubMed ID: 20524720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of 160 cases of statin-induced myopathy].
    Jiang Y; Lou Y; Liu Y; Wang L; Pang H; Zhang J; Zhou Y; Li Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Nov; 42(11):905-9. PubMed ID: 25620251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liability.
    Golightly LK; Barber GR; Barron MA; Page RL
    Drug Metabol Drug Interact; 2013; 28(1):49-58. PubMed ID: 23314530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striated muscle safety of ezetimibe/simvastatin (Vytorin).
    Davidson MH; Maccubbin D; Stepanavage M; Strony J; Musliner T
    Am J Cardiol; 2006 Jan; 97(2):223-8. PubMed ID: 16442367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical drug interactions in outpatients of a university hospital in Thailand.
    Janchawee B; Owatranporn T; Mahatthanatrakul W; Chongsuvivatwong V
    J Clin Pharm Ther; 2005 Dec; 30(6):583-90. PubMed ID: 16336291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemfibrozil-induced myositis in a patient with normal renal function.
    Hahn M; Sriharan K; McFarland MS
    Ann Pharmacother; 2010 Jan; 44(1):211-4. PubMed ID: 19934390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions.
    Alford JC; Saseen JJ; Allen RR; Nair KV
    Pharmacotherapy; 2012 Jul; 32(7):623-30. PubMed ID: 22570173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for a new tool to evaluate drug interaction cases.
    Horn JR; Hansten PD; Chan LN
    Ann Pharmacother; 2007 Apr; 41(4):674-80. PubMed ID: 17389673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series.
    Cham S; Koslik HJ; Golomb BA
    Drug Saf Case Rep; 2016 Dec; 3(1):1. PubMed ID: 27747681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin related adverse effects and patient education: a study from resource limited settings.
    Mulchandani R; Lyngdoh T; Chakraborty P; Kakkar AK
    Acta Cardiol; 2018 Aug; 73(4):393-401. PubMed ID: 29179650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low vitamin D as a risk factor for the development of myalgia in patients taking high-dose simvastatin: a retrospective review.
    Mergenhagen K; Ott M; Heckman K; Rubin LM; Kellick K
    Clin Ther; 2014 May; 36(5):770-7. PubMed ID: 24742497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medication management: Simvastatin and Amlodipin - a clinically relevant drug-interaction?].
    Schröder J; Goltz L; Knoth H
    Dtsch Med Wochenschr; 2016 Oct; 141(21):1575-1577. PubMed ID: 27750346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis associated with simvastatin-gemfibrozil therapy.
    Tal A; Rajeshawari M; Isley W
    South Med J; 1997 May; 90(5):546-7. PubMed ID: 9160078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Population-Based Study of Simvastatin Drug-Drug Interactions in Cardiovascular Disease Patients.
    Wang J; Chi CL; St Peter WL; Carlson A; Loth M; Pradhan PM; Liang Y; Chen WY; Lenskaia T; Robinson JG; Adam TJ
    AMIA Jt Summits Transl Sci Proc; 2020; 2020():664-673. PubMed ID: 32477689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia.
    Athyros VG; Papageorgiou AA; Hatzikonstandinou HA; Didangelos TP; Carina MV; Kranitsas DF; Kontopoulos AG
    Am J Cardiol; 1997 Sep; 80(5):608-13. PubMed ID: 9294990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.